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SEGURANÇA E EFICÁCIA DO HIDROGEL DE CARBOXIMETILCELULOSE À 2% EM ÚLCERAS DE PERNA* 
 
EVALUACIÓN DE LA SEGURIDAD Y EFICACIA DEL USO DEL HIDROGEL À 2% EN ULCERAS DE PIERNAS 
 
Luciana Miranda Rodrigues1, Beatriz Guitton Renaud Baptista de Oliveira2, Selma Rodrigues de Castilho3, Débora Omena Futuro4 
ABSTRACT 
Objective: The aim of this study is to assess the efficiency and safety on using hydrogel carboxymethylcellulose 2%, 
handled at university pharmacy in treatment of patients with leg ulcers.  Method: A non-controlled prospective clinic 
study with 20 patients took place from January to October 2010. Results: The efficiency assessment was performed 
through the wound area reduction and wound bed tissue alteration; the safety was assessed through observation and 
report of adverse events.  The data showed that 33.3% of the lesions presented total healing. Regarding the safety, 
only 2 patients reported pain, increase of the exudate and wound infection as possible adverse reaction to the use 
hydrogel as dressing, according to the Naranjo algorithm. Conclusion: The results let us consider that the hydrogel 2% 
can be considered efficient and safe for this type of lesion. Descriptors:  Nursing, Leg ulcers, Safety, Efficiency, 
Hydrogel. 
 
RESUMO 
Objetivo: Avaliar a eficácia e a segurança do uso do hidrogel a 2%, manipulado na farmácia universitária, no 
tratamento de pacientes com úlceras de perna. Método: Estudo clínico, prospectivo, não controlado, incluindo 20 
pacientes no período de janeiro a outubro de 2010. A avaliação da eficácia foi realizada através da redução e da 
alteração tecidual do leito da ferida. A segurança foi avaliada por observação e relato dos eventos adversos. 
Resultados: Os dados mostraram que 33,3% das lesões apresentaram cicatrização total. Quanto à segurança, apenas 2 
pacientes apresentaram dor, aumento de exsudato e infecção da ferida como reações adversas possíveis, segundo o 
algoritmo de Naranjo, ao uso do hidrogel 2% como curativo. Conclusão: Os resultados permitem considerar que o 
hidrogel de CMC a 2% mostrou-se eficaz e seguro para o tratamento desse tipo de lesão. Descritores: Enfermagem, 
Úlcera de perna, Segurança, Eficácia, Hidrogel. 
 
RESUMEN 
Objetivo: Es evaluar la eficacia y la seguridad del uso del Hidrogel 2%, manoseado en una farmacia docente, en el 
tratamiento de enfermos con úlceras de pierna.  Método:  El estudio clínico, no controlado, incluyó 20 pacientes en el 
periodo entre enero y octubre de 2010.  Resultados: La  evaluación de su eficacia fue comprobada  por la reducción de 
la herida y de la alteración de la piel en su interior. La seguridad fue evaluada por observación y el relato de los  
eventos adversos. Los dados han evidenciados que 33,3% de las lesiones presentaron cicatrización  total. Cuanto a la 
seguridad, solamente dos pacientes presentaron reacciones previsibles al uso del Hidrogel 2% como curativo.  
Conclusión: Se puede concluir que el Hidrogel 2% se muestra eficaz y seguro para el tratamiento de esto tipo de lesión. 
Descriptores: Enfermería, Úlceras de pierna, Seguridad, Eficacia, Hidrogel. 
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Leg ulcers are considered an important 
public health problem worldwide, being 
responsible for considerable economic impact, 
permanent pain and limitation, and various 
psychosocial problems, such as isolation, loss of 
self-esteem and away from work.1-3 The main 
causes of chronic ulcer of lower extremity venous 
diseases are responsible for about 60 to 70% .4 
Multiple products are available varying in 
relation to the physical and chemical 
characteristics, what influences in their 
effects. Several of them are registered and 
approved for the use in Brazil, which makes it 
important to verify the existence of clinical 
studies and accompanying information of 
pharmacovigilance to ensure the effectiveness and 
safety of these products. The efficacy of hidrogels 
for the treatment of wounds has been 
demonstrated in several studies.5-12 Adverse 
effects are divided into immediate and late and 
can range from mild edema and erythema to the 
lesional flatbed necrosis.13 
The search for new technologies and non-
invasive methods for correction of skin changes 
related to wounds and dressings is increasingly 
significant trend. The carboxymethylcellulose is a 
polymer used in the treatment of wounds in the 
form of Hydrogel. Such preparations are classified 
as primary dressings, showing excellence for 
hydration and maintaining a moist environment at 
the wound. The hydrogels have the property of 
absorbing, scaling and debride necrotic tissue and 
fibrotic.14-16 
GOAL 
  Evaluate the effectiveness and safety of 
the 2% of CMC Hydrogel produced masterfully in 
the Fluminense Federal University Pharmacy as a 
product for the treatment of chronic injuries of 
the leg ulcers. 
 
 
Study of therapeutic intervention, 
prospective, uncontrolled clinical trial on the 
safety and efficacy of the 2% of CMC Hydrogel 
produced in University pharmacy for the 
treatment of wounds in patients with leg 
ulcers. The Research Ethics Committee of the 
Fluminense Federal University of Medicine College 
(n0 0154.0.258.000-08) approved the study. Data 
collection occurred from January to October 
2010. Have been admitted in the study 20 
patients, according to random probability 
sampling, among those who were already in 
Outpatient monitoring of Tissue Repair. The main 
inclusion criteria for the study were: patients over 
18 years; they had indication for the use of CMC 
Hydrogel to 2%; absence of an infectious process 
in the injury; chronic leg injury present in one or 
both lower limbs, with stable or evolution in the 
process of increase of the lesion; had cognitive 
conditions so they could follow the recommended 
guidelines during the study period. The study 
showed a loss of 20% of the sample group (04), for 
the following reasons: occurrence of local and 
systemic infection (N=1) requiring the exchange of 
treatment; by request due to frequent pain 
complaints (N=1); for changing the psychic state 
(N=1); for health complications requiring 
hospitalization and remoteness of the study 
(N=1). Thus, 16 volunteers were accompanied by 
ninety days for the collection of data of each 
patient. 
The CMC Hydrogel 2% was produced in the 
Pharmacy College of Pharmacy University of 
Fluminense Federal University following the 
formulation of an amorphous gel and non-
sterile. Its composition was 2% 
carboxymethylcellulose, 0.1% methylparaben, 20% 
propyleneglycol and  77.9% purified water in 
bottles of 100 g. The production of a non-sterile 
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gel requires means of control of quality and 
effectiveness of the product periodically, thus the 
CMC Hydrogel 2% spent by Physical-Chemical 
Control processing and microbiological control. All 
the tests applied to the study product obtained 
satisfactory results. There is no impediment to its 
use in the study volunteers. 
The evaluation of the effectiveness of the CMC 
Hydrogel 2% came through the measurements of 
wounds evaluated routinely according to the 
protocols of research, having as parameters to 
reduce the size of the wounds and the changes of 
the tissue characteristics in four times: beginning 
of the treatment, 30, 60 and 90 days through 
biweekly registry of lesions with digital 
photography and decal. The technique of the 
overlay is accomplished through perimeter 
contour, sheets of transparent acetate; on the top 
sheet is drawn the outline of the wound, while 
who was in contact with the wound is 
overrated. The stroke is transferred to graph 
paper. The presence of epithelization, 
granulation, yellow slough and necrosis were 
evaluated using an ordinal scale validated for the 
study (table 1). Safety was evaluated by the 
report and observation of immediate adverse 
events/late mild, moderate or severe, such as 
erythema, pruritus, edema, infection, exudation, 
necrosis and pain. 
 
Image 1: Ordinal Scale Tissue classification. Niterói/RJ, 
2010. 
 
 
 
20 patients were treated with ages 
between 40 and 84 years, predominantly female 
(n = 10). After 90 days of treatment with the CMC 
Hydrogel to 2%, there was a change in the depth 
of the lesions in 43.7% of volunteers, with the 
absence of exudation in 25% and with moisturizing 
the edges of lesions in 56.25%. The results were 
excellent because 25% of patients had complete 
healing and 75% had reduced the size of the lesion 
or tissue change of the bed of the wound (table 
1). 
Table 1-Clinical characteristics of injuries of leg ulcers 
treated with CMC Hydrogel to 2% on the initial visit and 
after 90 days. Niterói/RJ, 2010 
Injury clinic 
Initial After 90 
days 
N % N % 
Depth of 
the 
lesion 
Superficial 4 25.00 7 43.75 
 Partial 12 75.00 5 31.25 
 Total 0 0.00 0 0.00 
 Missing 0 0.00 4 25.00 
Edema Missing 11 68.75 16 100.00 
 Discreet (+1) 0 0.00 0 0.00 
 Moderate 
(+2/+3) 
4 25.00 0 0.00 
 Intense (+4) 1 6.25 0 0.00 
Pain Missing 11 68.75 12 75.00 
  Light 0 0.00 0 0.00 
  Moderate 3 18.75 1 6.25 
  Intense 2 12.50 3 18.75 
Type of 
exudate 
Serous 9 56.25 8 50.00 
 Serosanguinolent 6 37.50 4 25.00 
 Purulent 1 6.25 0 0.00 
 Missing 0 0.00 4 25.00 
Amount 
of 
exudate 
Small 6 37.50 7 43.75 
 Average 5 31.25 3 18.75 
 Great 4 25.00 2 12.50 
 Missing 0 0.00 4 25.00 
Smell Missing 14 87.50 16 100.00 
 Present 2 12.50 0 0.00 
Edge Macerated 9 56.25 6 37.50 
 Hydrated 1 6.25 9 56.25 
  Desquamated 5 31.25 0 0.00 
TOTAL 16 100.0 16 100.0 
 
Security 
  After an interval that varied from 7 to 30 
days from the application of CMC Hydrogel to 2%, 
was observed in 2 volunteers, undesirable 
reactions, which, however, occur commonly in the 
treatment of chronic wounds, that is, they are 
predictable, such as pain after application, 
increased exudation and local infectious process 
(table 2). The Naranjo algorithm has classified 
RESULTS AND DISCUSSION 
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these reactions, as possible adverse 
reactions. There were no late reactions or 
cutaneous or systemic adverse events. 
 
Table 2– Distribution of the number of volunteers in 
accordance with the type of adverse reaction to 
treatment with CMC Hydrogel to 2%. Niterói/RJ, 2010. 
Types of 
reactions 
Immediate 
Reaction 
Late Reaction 
Yes Not Yes Not 
Edema 1 19 - 20 
Severe Pain 1 19 - 20 
Erythema - 20 - 20 
Infection 1 19 - 20 
Pruritus - 20 - 20 
 
 
 
Image 2– Evolution of wound bed tissue treated with 
CMC Hydrogel to 2% in 90 days of 
treatment. Niterói/RJ, 2010 
 
This study showed that the 2% of CMC 
Hydrogel was effective and safe for the treatment 
of leg ulcers improving the tissue bed and 
promoting healing of the lesions. 
It was found that in the first evaluation, 
namely at the beginning of treatment with the 
Hydrogel the CMC 2%, the higher prevalence in the 
wound bed was the yellow slough, by averaging 
3.75 ± 1.2 (image 2). After 90 days of treatment 
with the Hydrogel of CMC to 2%, was a reversal of 
the prevalence of tissue in wound bed type. The 
granulation tissue began to prevail in the wound 
bed with an average of 3.12 ± 1.0 (n = 8) and the 
development of the fabric of epithelization with 
1.68 ± 0.7 (n = 4) of presence in bed tissue. These 
results showed a degree of significance with p-
value of 0.0416 confirming this relationship 
inversely proportional. Other studies corroborate 
with what was found in this study according to the 
prevalence of lesions showing liquefy necrosis, 
granulation and fibrin to the detriment of 
granulation and epithelization and in another 
study it was found that 100% of surveyed have 
granulation tissue, 35% had woven epithelization, 
and 95% had fibrin and necrotic liquefying in your 
injuries.17-18 To several authors, the reduction of 
leg ulcers in the first three or four weeks of 
treatment is an important predictor of healing, 
indicating a good prognosis for most patients.19-20 
Still, were detected in patients in which there was 
no reduction of fibrin, most remained with their 
wounds until the 12th week of treatment, which 
reinforces the assertion that studies identify the 
presence of fibrin in 50% or more of the wound 
surface leads to injury to a worse prognosis. Still, 
say, hardly patients with unsatisfactory evolution 
of the bed will have their healed lesions, since the 
presence of non-viable tissues, as well as 
encourage infections, does not allow the 
formation of granulation tissue and proper good 
reepithelization.21-22 It is reasonable to assume 
that the satisfactory progress observed in the 
study can be attributed to the Hydrogel of CMC 
to 2%, since the gel promotes reduction of fibrin, 
through the autolytic debridement, as well as 
promote epithelization of the wound by wound 
bed maintenance hydrated.1.3 -4; 23-4 
In this study, there were no late reaction 
type. To achieve good results without serious 
complications is important that nurses learn to use 
and get to know the product and select the 
patient properly. It is essential to know the 
possible complications, identify them and treat 
them as early as possible. 
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Although it is a clinical study without 
control, the methodology employed allowed to 
estimate both the answer and the safety in the 
use of CMC Hydrogel to 2%. The results suggest 
that the use of Hydrogel of CMC to 2% handled 
masterfully in the pharmacy university contributed 
to acceleration of the healing process, showing to 
be effective and safe for the treatment of leg 
ulcers. However, the use of a product in the 
treatment of chronic wounds cannot be considered 
an isolated factor, and stimulate the adherence 
and patient involvement in self-care activities, as 
well as the provision of systematic assistance on 
the basis of the best scientific evidence. 
As the CMC Hydrogel to 2% is a cheap 
product (currently with the amount of R$ 8.00), 
its use can contribute to ensure patient 
compliance with leg ulcer treatment, since the 
access to the product is facilitated. 
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